NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

China says G4 swine flu virus not new; does not infect humans easily

Published 04/07/2020, 11:57
Updated 04/07/2020, 12:00
© Reuters. Pigs are seen at a family farm in Fuyang, Anhui

SHANGHAI/BEIJING (Reuters) - China's Ministry of Agriculture and Rural Affairs said on Saturday that the so-called "G4" strain of swine flu virus is not new and does not infect or sicken humans and animals easily, rebuffing a study published earlier this week.

That study, by a team of Chinese scientists and published by the U.S. journal Proceedings of the National Academy of Sciences (PNAS), warned that a new swine flu virus, named G4, has become more infectious to humans and could become a potential "pandemic virus".

However, China's agriculture ministry said in a statement that the study has been interpreted by the media "in an exaggerated and nonfactual way."

An analysis by the ministry concluded that sampling of the published study is too small to be representative, while the article lacks adequate evidence to show the G4 virus has become the dominant strain among pigs.

The ministry said it drew its conclusions after holding a seminar on the G4 virus's impact on the hog industry and public health. Participants included Chinese veterinarians and anti-virus experts, as well as the leading authors of the PNAS study.

The participants concurred that the G4 virus is not new, the statement said. Furthermore, such a strain has been monitored continuously by the World Health Organization (WHO) and related agencies in China since 2011, the statement said, citing a senior WHO official.

In addition, the authors of the published study agreed that the G4 virus does not effectively replicate in the human body and cause disease, according to the statement.

© Reuters. Pigs are seen at a family farm in Fuyang, Anhui

The ministry's statement was authored by Yang Hanchun, a swine viral disease scientist at China Agricultural University who also serves the role of expert on a ministry anti-epidemic committee.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.